The word “disability” evokes images of ramps, lower-positioned urinals, grab bars and other allowances in our architectural landscape. But an untold number of people have disabilities — from A.D.H.D. to addictive disorder to lupus — that aren’t necessarily helped by a reserved parking spot. A person who walks with a limp but uses no physical…

Late last month, the Food and Drug Administration approved the marketing for the first prescription video game to treat ADHD in children, a game titled Endeavor RX from Akili Interactive. This is a monumental achievement but it also symbolizes a bigger push in this space to tackle learning disabilities ranging ADHD to Autism.

Part 1: Lessons learned that can help you turn procrastination against itself. Procrastination has been deemed the quintessential self-regulatory failure—putting off tasks despite knowing you will be worse off as a consequence.1 Seeing as ADHD itself is a developmental problem of self-dysregulation—a chronic, persistent delay in the acquisition and employment of the foundational self-regulatory capacities,…

This post focuses on a few unorthodox coping strategies tailored to adult ADHD, including a couple of innovative adaptations by clients themselves, that helped to personalize the strategies to meet their needs.

There’s a new international consensus statement out on the topic of treating co-occurring ADHD and substance use disorder, specifically in teenagers. To put together the statement, 55 experts in 17 countries were polled to see whether they agreed with a variety of statements on the best practices for treating comorbid ADHD and substance use in…

Centanafadine, a novel investigational compound for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults, demonstrated statistically significant improvements compared with placebo in a pair of 6-week, phase 3 clinical trials, announced maker Otsuka Pharmaceutical Co. Ltd. and its US subsidiary Otsuka Pharmaceutical Development & Commercialization, Inc.

Researchers from Lehigh’s College of Education and Lehigh’s College of Business have been awarded a $3.29 million grant from the U.S. Department of Education’s Institute of Education Sciences (IES) to examine the effects of face-to-face and online behavioral parent education for young children at-risk for Attention-Deficit/Hyperactivity Disorder (ADHD).

Throughout the COVID-19 shelter-in-place mandates and in this early phase of business re-openings, adults with ADHD have struggled to manage their personal lives and household circumstances in this ongoing haze of uncertainty. Many of the typical coping strategies for managing ADHD are still relevant but must be adapted to the new demands of working, learning…

Timothy E. Wilens, MD, explains the effectiveness and safety of stimulant medications, and the outcomes of long-term studies on these treatments for ADHD.

ADHD Experts discuss the mechanism of action and the delivery system of ADHD medications including Mydayis, Intuniv, and Vyvanse, and the affect they have on patients.

If you are among the millions of adults in the U.S. who do not know they have attention-deficit/hyperactivity disorder (ADHD), the past several months of social distancing have been a particularly steep battle…It is a common misperception that ADHD, a neurodevelopmental disorder characterized by developmentally inappropriate levels of inattention, impulsivity and hyperactivity, only affects children.

The diagnosis and treatment of attention deficit hyperactivity disorder (ADHD) in children and teens can be a complex and unique challenge for primary care providers…Anxiety, depression, tics, or complex ADHD may be occurring, in which case treatment with ADHD medication may not be the correct approach and could also cause harmful adverse effects.